162 related articles for article (PubMed ID: 26353820)
1. Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc).
Polinski JM; Kim SC; Jiang D; Hassoun A; Shrank WH; Cos X; Rodríguez-Vigil E; Suzuki S; Matsuba I; Seeger JD; Eddings W; Brill G; Curtis BH
BMC Endocr Disord; 2015 Sep; 15():46. PubMed ID: 26353820
[TBL] [Abstract][Full Text] [Related]
2. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study.
Peyrot M; Barnett AH; Meneghini LF; Schumm-Draeger PM
Diabet Med; 2012 May; 29(5):682-9. PubMed ID: 22313123
[TBL] [Abstract][Full Text] [Related]
3. Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents.
Philis-Tsimikas A; Del Prato S; Satman I; Bhargava A; Dharmalingam M; Skjøth TV; Rasmussen S; Garber AJ
Diabetes Obes Metab; 2013 Aug; 15(8):760-6. PubMed ID: 23577643
[TBL] [Abstract][Full Text] [Related]
4. Impact of delaying treatment intensification with a glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes uncontrolled on basal insulin: A longitudinal study of a US administrative claims database.
Tong L; Pan C; Wang H; Bertolini M; Lew E; Meneghini LF
Diabetes Obes Metab; 2018 Apr; 20(4):831-839. PubMed ID: 29119712
[TBL] [Abstract][Full Text] [Related]
5. Challenges associated with insulin therapy progression among patients with type 2 diabetes: Latin American MOSAIc study baseline data.
Linetzky B; Curtis B; Frechtel G; Montenegro R; Escalante Pulido M; Stempa O; de Lana JM; Gagliardino JJ
Diabetol Metab Syndr; 2016; 8():41. PubMed ID: 27453733
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries.
Heintjes EM; Overbeek JA; Hall GC; Prieto-Alhambra D; Lapi F; Hammar N; Bezemer ID
Clin Ther; 2017 Nov; 39(11):2296-2310.e14. PubMed ID: 29108837
[TBL] [Abstract][Full Text] [Related]
7. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal assessment of the quality of life and patterns of antidiabetic medication use in patients with type 2 diabetes, Saudi Arabia perspective, DISCOVER study.
Al-Rubeaan K; Banah F; Alruwaily FG; Sheshah E; Alnaqeb D; AlQahtani AM; Ewais D; Al Juhani N; Hassan AH; Youssef AM
Curr Med Res Opin; 2023 Jan; 39(1):27-35. PubMed ID: 36342972
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
Yurgin N; Secnik K; Lage MJ
Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
[TBL] [Abstract][Full Text] [Related]
10. Influence of Treatment Intensification on A1c in Patients with Suboptimally Controlled Type 2 Diabetes After 2 Oral Antidiabetic Agents.
Kim K; Unni S; McAdam-Marx C; Thomas SM; Sterling KL; Olsen CJ; Johnstone B; Mitchell M; Brixner D
J Manag Care Spec Pharm; 2019 Mar; 25(3):314-322. PubMed ID: 30816811
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal change in HbA1c after insulin initiation in primary care patients with type 2 diabetes: a database analysis in UK and Germany.
Rathmann W; Strassburger K; Tamayo T; Kostev K
Prim Care Diabetes; 2012 Apr; 6(1):47-52. PubMed ID: 22099215
[TBL] [Abstract][Full Text] [Related]
12. Slow Titration and Delayed Intensification of Basal Insulin Among Patients with Type 2 Diabetes.
Mocarski M; Yeaw J; Divino V; DeKoven M; Guerrero G; Langer J; Thorsted BL
J Manag Care Spec Pharm; 2018 Apr; 24(4):390-400. PubMed ID: 29406841
[TBL] [Abstract][Full Text] [Related]
13. Exploring the role of the patient-physician relationship on insulin adherence and clinical outcomes in type 2 diabetes: Insights from the MOSAIc study.
Linetzky B; Jiang D; Funnell MM; Curtis BH; Polonsky WH
J Diabetes; 2017 Jun; 9(6):596-605. PubMed ID: 27368146
[TBL] [Abstract][Full Text] [Related]
14. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.
Khutsoane D; Sharma SK; Almustafa M; Jang HC; Azar ST; Danciulescu R; Shestakova M; Ayad NM; Guler S; Bech OM;
Diabetes Obes Metab; 2008 Mar; 10(3):212-22. PubMed ID: 18269636
[TBL] [Abstract][Full Text] [Related]
15. Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes: results from the Observational Registry of Basal Insulin Treatment (ORBIT).
Gao L; Zhang P; Weng J; Lu J; Guo X; Jia W; Yang W; Zou D; Zhou Z; Pan C; Gao Y; Li X; Zhu D; Wu Y; Garg SK; Ji L
J Diabetes; 2020 Sep; 12(9):668-676. PubMed ID: 32329194
[TBL] [Abstract][Full Text] [Related]
16. Treatment intensification for patients with type 2 diabetes and poor glycaemic control.
Fu AZ; Sheehan JJ
Diabetes Obes Metab; 2016 Sep; 18(9):892-8. PubMed ID: 27160505
[TBL] [Abstract][Full Text] [Related]
17. Clinical Determinants of Diabetes Progression in Multiethnic Asians with Type 2 Diabetes - A 3-Year Prospective Cohort Study.
Liu S; Liu JJ; Gurung RL; Chan C; Yeo D; Ang K; Tang WE; Tavintharan S; Sum CF; Lim SC
Ann Acad Med Singap; 2019 Jul; 48(7):217-223. PubMed ID: 31495867
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study.
Pfohl M; Siegmund T; Pscherer S; Pegelow K; Seufert J
Vasc Health Risk Manag; 2015; 11():569-78. PubMed ID: 26604774
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002.
Fox KM; Gerber Pharmd RA; Bolinder B; Chen J; Kumar S
Clin Ther; 2006 Mar; 28(3):388-95. PubMed ID: 16750453
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with injection omission/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy study.
Peyrot M; Barnett AH; Meneghini LF; Schumm-Draeger PM
Diabetes Obes Metab; 2012 Dec; 14(12):1081-7. PubMed ID: 22726104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
